NVYTF Stock Novacyt Clamart (NVYTF, $0.48) was a top loser this week, declining -5.9%
at Tickeron.com
Loading...
Novacyt Clamart (NVYTF, $0.48) was a top weekly loser, falling to $0.48 per share. Of the 218 stocks analyzed in the Medical/Nursing Services Industry throughout the week of December 26, 2025 - January 2, 2026, of them (4) exhibited an Uptrend while of them (5) were in a Downtrend.
NVYTF in downward trend: 10-day moving average broke below 50-day moving average on January 02, 2026
The 10-day moving average for NVYTF crossed bearishly below the 50-day moving average on January 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on January 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NVYTF as a result. In of 38 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
NVYTF moved below its 50-day moving average on January 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.617) is normal, around the industry mean (62.991). P/E Ratio (0.000) is within average values for comparable stocks, (38.209). NVYTF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.662). NVYTF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (1.294) is also within normal values, averaging (39.712).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVYTF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVYTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Advertisement
General Information
Industry MedicalNursingServices